3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Sell
26
RGNX Quote, Financials, Valuation and Earnings
Last price:
$6.89
Seasonality move
:
4.59%
Day range:
$6.77 - $7.46
52-week range:
$5.62 - $21.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.25x
P/B ratio:
1.38x
Volume:
1M
Avg. volume:
951.4K
1-year change:
-66.07%
Market cap:
$358.1M
Revenue:
$83.3M
EPS (TTM):
-$4.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $154.6M | $470.3M | $112.7M | $90.2M | $83.3M | |
| Revenue Growth (YoY) | 338.7% | 204.3% | -76.03% | -19.94% | -7.66% | |
| Cost of Revenues | $35.7M | $51.8M | $54.5M | $37.2M | $33.6M | |
| Gross Profit | $118.9M | $418.5M | $58.2M | $53M | $49.8M | |
| Gross Profit Margin | 76.89% | 88.98% | 51.61% | 58.76% | 59.72% | |
| R&D Expenses | $166.3M | $181.4M | $242.5M | $232.3M | $208.5M | |
| Selling, General & Admin | $63.8M | $79.3M | $85.3M | $88.5M | $76.6M | |
| Other Inc / (Exp) | $9.7M | $6.8M | $5.4M | $11.3M | $16.6M | |
| Operating Expenses | $238.1M | $258.5M | $321.1M | $321.2M | $281M | |
| Operating Income | -$119.2M | $160M | -$262.9M | -$268.1M | -$231.2M | |
| Net Interest Expenses | -- | $25.6M | $22.9M | $6.8M | $12.5M | |
| EBT. Incl. Unusual Items | -$106M | $141.2M | -$280.4M | -$263.6M | -$227.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.2M | $13.4M | -$84K | -$152K | -- | |
| Net Income to Company | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Basic EPS (Cont. Ops) | -$2.98 | $3.01 | -$6.50 | -$6.02 | -$4.59 | |
| Diluted EPS (Cont. Ops) | -$2.98 | $2.91 | -$6.50 | -$6.02 | -$4.59 | |
| Weighted Average Basic Share | $37.3M | $42.4M | $43.2M | $43.7M | $49.5M | |
| Weighted Average Diluted Share | $37.3M | $43.9M | $43.2M | $43.7M | $49.5M | |
| EBITDA | -$96.8M | $177.1M | -$244.2M | -$239.5M | -$198.2M | |
| EBIT | -$105.2M | $167.5M | -$257.2M | -$256.8M | -$214.4M | |
| Revenue (Reported) | $154.6M | $470.3M | $112.7M | $90.2M | $83.3M | |
| Operating Income (Reported) | -$119.2M | $160M | -$262.9M | -$268.1M | -$231.2M | |
| Operating Income (Adjusted) | -$105.2M | $167.5M | -$257.2M | -$256.8M | -$214.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4M | $398.7M | $31.3M | $22.2M | $21.2M | |
| Revenue Growth (YoY) | 82.23% | 1758.97% | -92.14% | -29.13% | -4.5% | |
| Cost of Revenues | $10.3M | $23.1M | $12.8M | $11.2M | $6.3M | |
| Gross Profit | $11.2M | $375.6M | $18.6M | $11M | $14.9M | |
| Gross Profit Margin | 52.17% | 94.22% | 59.22% | 49.41% | 70.22% | |
| R&D Expenses | $47.2M | $48M | $62.5M | $55.7M | $50.4M | |
| Selling, General & Admin | $17.6M | $22M | $21.2M | $19.1M | $20.1M | |
| Other Inc / (Exp) | $13.8M | $311K | $2M | $2.4M | $9.5M | |
| Operating Expenses | $64.8M | $62M | $76.3M | $74.9M | $66.3M | |
| Operating Income | -$53.7M | $313.6M | -$57.8M | -$63.9M | -$51.4M | |
| Net Interest Expenses | $641K | $6.5M | $4.2M | $1.5M | $9.3M | |
| EBT. Incl. Unusual Items | -$40.5M | $307.4M | -$60M | -$63M | -$51.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.7M | $13.4M | -$43K | -- | -- | |
| Net Income to Company | -$46.2M | $294M | -$59.9M | -$62.9M | -$51.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$46.2M | $294M | -$59.9M | -$62.9M | -$51.2M | |
| Basic EPS (Cont. Ops) | -$1.24 | $6.87 | -$1.38 | -$1.42 | -$1.01 | |
| Diluted EPS (Cont. Ops) | -$1.24 | $6.67 | -$1.38 | -$1.42 | -$1.01 | |
| Weighted Average Basic Share | $37.4M | $42.8M | $43.3M | $44M | $50.9M | |
| Weighted Average Diluted Share | $37.4M | $48.7M | $43.3M | $44M | $50.9M | |
| EBITDA | -$37.6M | $316.5M | -$51.5M | -$57.3M | -$37.7M | |
| EBIT | -$39.7M | $313.9M | -$55.7M | -$61.7M | -$41.8M | |
| Revenue (Reported) | $21.4M | $398.7M | $31.3M | $22.2M | $21.2M | |
| Operating Income (Reported) | -$53.7M | $313.6M | -$57.8M | -$63.9M | -$51.4M | |
| Operating Income (Adjusted) | -$39.7M | $313.9M | -$55.7M | -$61.7M | -$41.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $154.6M | $470.3M | $112.7M | $90.2M | $83.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $35.7M | $51.8M | $54.5M | $37.2M | $33.6M | |
| Gross Profit | $118.9M | $418.5M | $58.2M | $53M | $49.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $166.3M | $181.4M | $242.5M | $232.3M | $208.5M | |
| Selling, General & Admin | $63.8M | $79.3M | $85.3M | $88.5M | $76.6M | |
| Other Inc / (Exp) | $9.7M | $6.8M | $5.4M | $11.3M | $16.6M | |
| Operating Expenses | $238.1M | $258.5M | $321.1M | $321.2M | $281M | |
| Operating Income | -$119.2M | $160M | -$262.9M | -$268.1M | -$231.2M | |
| Net Interest Expenses | -- | $25.6M | $22.9M | $6.8M | $12.5M | |
| EBT. Incl. Unusual Items | -$106M | $141.2M | -$280.4M | -$263.6M | -$227.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.2M | $13.4M | -$84K | -- | -- | |
| Net Income to Company | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Basic EPS (Cont. Ops) | -$2.99 | $2.94 | -$6.50 | -$6.02 | -$4.61 | |
| Diluted EPS (Cont. Ops) | -$3.00 | $2.74 | -$6.50 | -$6.02 | -$4.61 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$96.8M | $177.1M | -$244.2M | -$239.5M | -$198.2M | |
| EBIT | -$105.2M | $167.5M | -$257.2M | -$256.8M | -$214.4M | |
| Revenue (Reported) | $154.6M | $470.3M | $112.7M | $90.2M | $83.3M | |
| Operating Income (Reported) | -$119.2M | $160M | -$262.9M | -$268.1M | -$231.2M | |
| Operating Income (Adjusted) | -$105.2M | $167.5M | -$257.2M | -$256.8M | -$214.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $470.3M | $112.7M | $90.2M | $83.3M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $51.8M | $54.5M | $37.2M | $33.6M | -- | |
| Gross Profit | $418.5M | $58.2M | $53M | $49.8M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $181.4M | $242.5M | $232.3M | $208.5M | -- | |
| Selling, General & Admin | $79.3M | $85.3M | $88.5M | $76.6M | -- | |
| Other Inc / (Exp) | $6.8M | $5.4M | $11.3M | $16.6M | -- | |
| Operating Expenses | $258.5M | $321.1M | $321.2M | $281M | -- | |
| Operating Income | $160M | -$262.9M | -$268.1M | -$231.2M | -- | |
| Net Interest Expenses | $25.6M | $22.9M | $6.8M | $12.5M | -- | |
| EBT. Incl. Unusual Items | $141.2M | -$280.4M | -$263.6M | -$227.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.4M | -$84K | -- | -- | -- | |
| Net Income to Company | $127.8M | -$280.3M | -$263.5M | -$227.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $127.8M | -$280.3M | -$263.5M | -$227.1M | -- | |
| Basic EPS (Cont. Ops) | $2.94 | -$6.50 | -$6.02 | -$4.61 | -- | |
| Diluted EPS (Cont. Ops) | $2.74 | -$6.50 | -$6.02 | -$4.61 | -- | |
| Weighted Average Basic Share | $169.7M | $172.6M | $174.9M | $198M | -- | |
| Weighted Average Diluted Share | $175.6M | $172.6M | $174.9M | $198M | -- | |
| EBITDA | $177.1M | -$244.2M | -$239.5M | -$198.2M | -- | |
| EBIT | $167.5M | -$257.2M | -$256.8M | -$214.4M | -- | |
| Revenue (Reported) | $470.3M | $112.7M | $90.2M | $83.3M | -- | |
| Operating Income (Reported) | $160M | -$262.9M | -$268.1M | -$231.2M | -- | |
| Operating Income (Adjusted) | $167.5M | -$257.2M | -$256.8M | -$214.4M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $338.4M | $345.2M | $97M | $34.5M | $57.5M | |
| Short Term Investments | $137.3M | $112.2M | $267.7M | $240.7M | $177.2M | |
| Accounts Receivable, Net | $30.6M | $365K | $280K | $4.9M | $65K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.5M | $18.8M | $13.9M | $14.5M | $9.1M | |
| Other Current Assets | $2M | $10.2M | $7.1M | $18.9M | $12.7M | |
| Total Current Assets | $531.2M | $518.8M | $416M | $335M | $278M | |
| Property Plant And Equipment | $120.3M | $192.5M | $206.8M | $192.6M | $171.3M | |
| Long-Term Investments | $46.8M | $391.9M | $200.6M | $38.9M | $10.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.6M | $8.5M | $8.4M | $6.8M | $6M | |
| Total Assets | $708.2M | $1.1B | $833.3M | $574M | $466M | |
| Accounts Payable | $10.6M | $11.4M | $27.2M | $22.8M | $22.8M | |
| Accrued Expenses | $32.8M | $44.9M | $28.7M | $31.6M | $20.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.5M | $1.8M | $6M | $7.1M | $7.9M | |
| Other Current Liabilities | $18.8M | $37.9M | $48.6M | $50.6M | $34.3M | |
| Total Current Liabilities | $81.4M | $130.5M | $130.4M | $130.3M | $103.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $330.4M | $349.6M | $317.1M | $262.2M | $206.3M | |
| Common Stock | $4K | $4K | $4K | $4K | $5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $377.8M | $764.3M | $516.2M | $311.7M | $259.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $377.8M | $764.3M | $516.2M | $311.7M | $259.7M | |
| Total Liabilities and Equity | $708.2M | $1.1B | $833.3M | $574M | $466M | |
| Cash and Short Terms | $475.7M | $457.4M | $364.6M | $275.3M | $234.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $338.4M | $345.2M | $97M | $34.5M | $57.5M | |
| Short Term Investments | $137.3M | $112.2M | $267.7M | $240.7M | $177.2M | |
| Accounts Receivable, Net | $30.6M | $365K | $280K | $4.9M | $65K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.5M | $18.8M | $13.9M | $14.5M | $9.1M | |
| Other Current Assets | $2M | $10.2M | $7.1M | $18.9M | $12.7M | |
| Total Current Assets | $531.2M | $518.8M | $416M | $335M | $278M | |
| Property Plant And Equipment | $120.3M | $192.5M | $206.8M | $192.6M | $171.3M | |
| Long-Term Investments | $46.8M | $391.9M | $200.6M | $38.9M | $10.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.6M | $8.5M | $8.4M | $6.8M | $6M | |
| Total Assets | $708.2M | $1.1B | $833.3M | $574M | $466M | |
| Accounts Payable | $10.6M | $11.4M | $27.2M | $22.8M | $22.8M | |
| Accrued Expenses | $32.8M | $44.9M | $28.7M | $31.6M | $20.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.5M | $1.8M | $6M | $7.1M | $7.9M | |
| Other Current Liabilities | $18.8M | $37.9M | $48.6M | $50.6M | $34.3M | |
| Total Current Liabilities | $81.4M | $130.5M | $130.4M | $130.3M | $103.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $330.4M | $349.6M | $317.1M | $262.2M | $206.3M | |
| Common Stock | $4K | $4K | $4K | $4K | $5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $377.8M | $764.3M | $516.2M | $311.7M | $259.7M | |
| Total Liabilities and Equity | $708.2M | $1.1B | $833.3M | $574M | $466M | |
| Cash and Short Terms | $475.7M | $457.4M | $364.6M | $275.3M | $234.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Depreciation & Amoritzation | $8.4M | $9.6M | $12.9M | $17.3M | $16.2M | |
| Stock-Based Compensation | $31.9M | $38.8M | $40.8M | $40.3M | $38.5M | |
| Change in Accounts Receivable | -$9.9M | $14.1M | $4.8M | $3.9M | $9.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$54.1M | $218.9M | -$207.5M | -$218.4M | -$173.1M | |
| Capital Expenditures | $26.9M | $84.2M | $30.7M | $10M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $122.8M | -$406.6M | -$11.9M | $190.9M | $103.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $192.8M | -$27.2M | -$33.4M | -$43.2M | -$41.1M | |
| Cash From Financing | $200.2M | $195.3M | -$28.8M | -$35M | $92.7M | |
| Beginning Cash (CF) | $70.8M | $339.8M | $347.2M | $99M | $36.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $268.9M | $7.5M | -$248.3M | -$62.4M | $23M | |
| Ending Cash (CF) | $339.8M | $347.2M | $99M | $36.6M | $59.6M | |
| Levered Free Cash Flow | -$80.9M | $134.7M | -$238.2M | -$228.4M | -$175.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$46.2M | $294M | -$59.9M | -$62.9M | -$51.2M | |
| Depreciation & Amoritzation | $2.1M | $2.6M | $4.1M | $4.3M | $4M | |
| Stock-Based Compensation | $7.6M | $9.2M | $9.4M | $8.3M | $9.5M | |
| Change in Accounts Receivable | $79.5M | $22M | $4.8M | $3.4M | $8.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $39.5M | $341.5M | -$39.4M | -$40.8M | -$31.6M | |
| Capital Expenditures | $12.9M | $14.6M | $5.5M | $1.1M | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $11.6M | -$216.4M | $26.7M | $34M | $40.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$8.6M | -$9M | -$12.2M | -$7.8M | |
| Cash From Financing | $194.2M | -$7.6M | -$8.9M | -$12M | -$7.7M | |
| Beginning Cash (CF) | $94.6M | $229.7M | $120.6M | $55.3M | $58.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $245.2M | $117.5M | -$21.6M | -$18.7M | $909K | |
| Ending Cash (CF) | $339.8M | $347.2M | $99M | $36.6M | $59.6M | |
| Levered Free Cash Flow | $26.6M | $326.9M | -$44.8M | -$41.9M | -$32.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$111.3M | $127.8M | -$280.3M | -$263.5M | -$227.1M | |
| Depreciation & Amoritzation | $8.4M | $9.6M | $12.9M | $17.3M | $16.2M | |
| Stock-Based Compensation | $31.9M | $38.8M | $40.8M | $40.3M | $38.5M | |
| Change in Accounts Receivable | -$9.9M | $14.1M | $4.8M | $3.9M | $9.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$54.1M | $218.9M | -$207.5M | -$218.4M | -$173.1M | |
| Capital Expenditures | $26.9M | $84.2M | $30.7M | $10M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $122.8M | -$406.6M | -$11.9M | $190.9M | $103.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$27.2M | -$33.4M | -$43.2M | -$41.1M | |
| Cash From Financing | $200.2M | $195.3M | -$28.8M | -$35M | $92.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $268.9M | $7.5M | -$248.3M | -$62.4M | $23M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$80.9M | $134.7M | -$238.2M | -$228.4M | -$175.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $127.8M | -$280.3M | -$263.5M | -$227.1M | -- | |
| Depreciation & Amoritzation | $9.6M | $12.9M | $17.3M | $16.2M | -- | |
| Stock-Based Compensation | $38.8M | $40.8M | $40.3M | $38.5M | -- | |
| Change in Accounts Receivable | $14.1M | $4.8M | $3.9M | $9.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $218.9M | -$207.5M | -$218.4M | -$173.1M | -- | |
| Capital Expenditures | $84.2M | $30.7M | $10M | $2.4M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$406.6M | -$11.9M | $190.9M | $103.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$27.2M | -$33.4M | -$43.2M | -$41.1M | -- | |
| Cash From Financing | $195.3M | -$28.8M | -$35M | $92.7M | -- | |
| Beginning Cash (CF) | $1.1B | $785.1M | $297.3M | $270M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.5M | -$248.3M | -$62.4M | $23M | -- | |
| Ending Cash (CF) | $1.1B | $536.9M | $234.8M | $293M | -- | |
| Levered Free Cash Flow | $134.7M | -$238.2M | -$228.4M | -$175.6M | -- | |
Get RGNX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RGNX
Sector
P/E ratio
--
24.27x
PEG ratio
--
0.00x
P/B ratio
1.38x
1.65x
Price / LTM sales
4.25x
1.65x
Growth Metrics
RGNX
Sector
Revenue growth
-4.5%
6.42%
Earnings growth
--
6.56%
Revenue (5-year growth)
18.79%
8.85%
Earnings forecast
$0.34
-$0.19
Profitability
RGNX
Sector
Profitability FY 2024
$49.8M
$56.7M
Return on invested capital
-70.45%
-14.28%
Return on assets
-41.18%
-11.83%
Return on equity
-70.45%
-16.73%
Earnings Date
Last Earnings Date
Mar
13
Next Earnings Date
May
8
Estimated Next Earnings Date
Jun
12
Balance Sheet
RGNX
Sector
Total cash
$234.7M
$41.7M
Short term investments
$177.2M
$39.2M
Total assets
$466M
$126.6M
Long term debt
--
$10.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 15.17% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 3.39% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 4.55% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
